Sort   by:  
 Page size 
UnknownAtrial fibrillation and stroke prevention: 25 years of research at EP Europace journal.
Not available
S-EPMC10451006 | biostudies-literature
UnknownNon-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice: barriers to and strategies for optimal implementation.
Not available
S-EPMC4482288 | biostudies-literature
UnknownAnticoagulation in Patients With Device-Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: The NOAH-AFNET 6 Trial.
Not available
S-EPMC11646511 | biostudies-literature
UnknownCardiovascular care of patients with stroke and high risk of stroke: The need for interdisciplinary action: A consensus report from the European Society of Cardiology Cardiovascular Round Table.
Not available
S-EPMC7227126 | biostudies-literature
UnknownAnticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 h.
Not available
S-EPMC10919916 | biostudies-literature
UnknownAnticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials.
Not available
S-EPMC11631065 | biostudies-literature
UnknownRecent-onset atrial fibrillation: challenges and opportunities.
Not available
S-EPMC12777708 | biostudies-literature
UnknownInternational longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER).
Not available
S-EPMC6482585 | biostudies-literature
UnknownAzithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC7884931 | biostudies-literature
UnknownEmpagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483 | biostudies-literature
Sort   by:  
 Page size